✦ LIBER ✦

P0168 Cotargeting MAPK and CDK4 signaling with concurrent radiotherapy as a strategy for the treatment of non-small-cell lung cancer

✍ Scribed by Tao, Z.; Yuan, Z.; Sun, Y.; LeBlanc, J.; Dicker, A.P.; Lu, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of S-1 and cisplatin with

✍ Ohyanagi, F; Yamamoto, N; Horiike, A; Harada, H; Kozuka, T; Murakami, H; Gomi, K 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 164 KB

TargetingALK: a promising strategy for t

✍ Andres Morales La Madrid, Nicholas Campbell, Sonali Smith, Susan L. Cohn, Ravi S 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 454 KB

258 Concurrent hyperfractionated thoraci

✍ Koinumaru, S.; Saito, J.; Nakai, Y. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 150 KB

Concurrent approaches to combined chemot

✍ JOHNSON, B 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 500 KB

A phase I study of irinotecan and carbop

✍ T. Kurata; M. Yamada; S. Kudoh; N. Yamamoto; K. Nakagawa; K. Takeda; S. Negoro; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 177 KB

P-520 Navelbine oral with cisplatin as i

✍ Krzakowski, M.; Provencio, M.; Utracka-Hutka, B.; Villa, E.; Codes, M.; Kuten, A 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB